176 related articles for article (PubMed ID: 16676183)
1. DC-based vaccine loaded with acid-eluted peptides in acute myeloid leukemia: the importance of choosing the best elution method.
Delluc S; Tourneur L; Fradelizi D; Rubio MT; Marchiol-Fournigault C; Chiocchia G; Buzyn A
Cancer Immunol Immunother; 2007 Jan; 56(1):1-12. PubMed ID: 16676183
[TBL] [Abstract][Full Text] [Related]
2. Autologous peptides eluted from acute myeloid leukemia cells can be used to generate specific antileukemic CD4 helper and CD8 cytotoxic T lymphocyte responses in vitro.
Delluc S; Tourneur L; Michallet AS; Boix C; Varet B; Fradelizi D; Guillet JG; Buzyn A
Haematologica; 2005 Aug; 90(8):1050-62. PubMed ID: 16079104
[TBL] [Abstract][Full Text] [Related]
3. Dramatic efficacy improvement of a DC-based vaccine against AML by CD25 T cell depletion allowing the induction of a long-lasting T cell response.
Delluc S; Hachem P; Rusakiewicz S; Gaston A; Marchiol-Fournigault C; Tourneur L; Babchia N; Fradelizi D; Regnault A; Sang KH; Chiocchia G; Buzyn A
Cancer Immunol Immunother; 2009 Oct; 58(10):1669-77. PubMed ID: 19225777
[TBL] [Abstract][Full Text] [Related]
4. Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination.
Galea-Lauri J; Darling D; Mufti G; Harrison P; Farzaneh F
Cancer Immunol Immunother; 2002 Aug; 51(6):299-310. PubMed ID: 12111118
[TBL] [Abstract][Full Text] [Related]
5. Tumor-peptide-pulsed dendritic cells isolated from spleen or cultured in vitro from bone marrow precursors can provide protection against tumor challenge.
Hermans IF; Daish A; Moroni-Rawson P; Ronchese F
Cancer Immunol Immunother; 1997 Aug; 44(6):341-7. PubMed ID: 9298937
[TBL] [Abstract][Full Text] [Related]
6. [In vitro stimulation of specific antileukemia T-cell response by dendritic cells derived from CD14+ acute monocytic leukemia cells].
Sheng LX; Xie XB; Qiu GQ; Gu WY; Wang ZL; Wu HQ
Ai Zheng; 2005 Nov; 24(11):1338-44. PubMed ID: 16552959
[TBL] [Abstract][Full Text] [Related]
7. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines.
Zitvogel L; Mayordomo JI; Tjandrawan T; DeLeo AB; Clarke MR; Lotze MT; Storkus WJ
J Exp Med; 1996 Jan; 183(1):87-97. PubMed ID: 8551248
[TBL] [Abstract][Full Text] [Related]
8. Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias.
Charbonnier A; Gaugler B; Sainty D; Lafage-Pochitaloff M; Olive D
Eur J Immunol; 1999 Aug; 29(8):2567-78. PubMed ID: 10458772
[TBL] [Abstract][Full Text] [Related]
9. Targeting of the WT1
Dagvadorj N; Deuretzbacher A; Weisenberger D; Baumeister E; Trebing J; Lang I; Köchel C; Kapp M; Kapp K; Beilhack A; Hünig T; Einsele H; Wajant H; Grigoleit GU
Cancer Immunol Immunother; 2017 Mar; 66(3):319-332. PubMed ID: 27896368
[TBL] [Abstract][Full Text] [Related]
10. Induction of BCR-ABL-specific immunity following vaccination with chaperone-rich cell lysates derived from BCR-ABL+ tumor cells.
Zeng Y; Graner MW; Thompson S; Marron M; Katsanis E
Blood; 2005 Mar; 105(5):2016-22. PubMed ID: 15374884
[TBL] [Abstract][Full Text] [Related]
11. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo.
Paglia P; Chiodoni C; Rodolfo M; Colombo MP
J Exp Med; 1996 Jan; 183(1):317-22. PubMed ID: 8551239
[TBL] [Abstract][Full Text] [Related]
12. Activation of autologous leukemia-specific T cells in acute myeloid leukemia: monocyte-derived dendritic cells cocultured with leukemic blasts compared with leukemia-derived dendritic cells.
Draube A; Beyer M; Wolf J
Eur J Haematol; 2008 Oct; 81(4):281-8. PubMed ID: 18573171
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on activating antileukemic T cells by vaccination with dendritic cells pulsed with survivin].
Zhang XH; Xia LH; Liu ZP; Wei WN; Hu Y; Song SJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):66-9. PubMed ID: 12667293
[TBL] [Abstract][Full Text] [Related]
14. Employing the immunological synapse in AML: development of leukemic dendritic cells for active specific immunization.
Houtenbos I; Westers TM; Ossenkoppele GJ; van de Loosdrecht AA
Immunobiology; 2005; 210(2-4):249-57. PubMed ID: 16164032
[TBL] [Abstract][Full Text] [Related]
15. Exosomes as potent cell-free peptide-based vaccine. I. Dendritic cell-derived exosomes transfer functional MHC class I/peptide complexes to dendritic cells.
André F; Chaput N; Schartz NE; Flament C; Aubert N; Bernard J; Lemonnier F; Raposo G; Escudier B; Hsu DH; Tursz T; Amigorena S; Angevin E; Zitvogel L
J Immunol; 2004 Feb; 172(4):2126-36. PubMed ID: 14764678
[TBL] [Abstract][Full Text] [Related]
16. Rationale for dendritic cell-based vaccines for acute myeloid leukemia.
Biragyn A
Haematologica; 2005 Aug; 90(8):1010C. PubMed ID: 16079091
[No Abstract] [Full Text] [Related]
17. Dendritic cells (DCs) can be successfully generated from leukemic blasts in individual patients with AML or MDS: an evaluation of different methods.
Kremser A; Dressig J; Grabrucker C; Liepert A; Kroell T; Scholl N; Schmid C; Tischer J; Kufner S; Salih H; Kolb HJ; Schmetzer H
J Immunother; 2010; 33(2):185-99. PubMed ID: 20139775
[TBL] [Abstract][Full Text] [Related]
18. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
[TBL] [Abstract][Full Text] [Related]
19. Vaccination with leukemia-loaded dendritic cells eradicates residual disease and prevent relapse.
Deeb D; Gao X; Jiang H; Divine G; Dulchavsky SA; Gautam SC
J Exp Ther Oncol; 2006; 5(3):183-93. PubMed ID: 16528969
[TBL] [Abstract][Full Text] [Related]
20. New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.
Subklewe M; Geiger C; Lichtenegger FS; Javorovic M; Kvalheim G; Schendel DJ; Bigalke I
Cancer Immunol Immunother; 2014 Oct; 63(10):1093-103. PubMed ID: 25186611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
